← Eichor
Condition: Sars Cov 2 Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Sars Cov 2

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Kisspeptin to Quantify GnRH Neuronal Function in Health and Disease
Phase 1 · 1 location(s) · Stephanie B. Seminara, MD · NCT07224490
Impact of Post-ARDS Covid-19 Sedation on Persistent Neuroinflammation
Phase N/A · 1 location(s) · Assistance Publique - Hôpitaux de Paris · NCT05233605
Passive Detection- SARS-CoV-2 (COVID-19) A&M Breathalyzer (PROTECT Kiosk) for Operational Medicine
Phase N/A · 1 location(s) · The Geneva Foundation · NCT06402318
Safety and Effectiveness of a Remdesivir Treatment to Prevent Severe COVID-19 in Kidney Transplant Patients
Phase 2 · 1 location(s) · Fundación FLS de Lucha Contra el Sida, las Enfermedades Infe · NCT07197164
Patient Outcome of Cardiac Surgery During the COVID-19 Pandemic
Phase N/A · 1 location(s) · Nantes University Hospital · NCT04389463
Exercise in Child Health
NA · 1 location(s) · University of California, Irvine · NCT05359991
SARS-CoV-2 Specific Antibody Responses and Impact for COVID-19 Disease in Ethiopia
Phase N/A · 2 location(s) · Michael Hoelscher · NCT06435403
COVID-19 Transmission and Morbidity in Malawi
Phase N/A · 2 location(s) · Boston University · NCT05973084
Effect of 2-HOBA in Persistent Immune Activation in Long COVID POTS
Phase 2 · 1 location(s) · Vanderbilt University Medical Center · NCT07189936
Evaluating the Impact of a Functional and Cognitive Strategy in Patients With Long Covid-19
NA · 1 location(s) · Fundación Cardioinfantil Instituto de Cardiología · NCT06871293
Positron Emission Tomography (PET) Imaging of Neuroinflammation in Patients With Neurological Dysfunction After Severe A
EARLY_Phase 1 · 1 location(s) · University of Alabama at Birmingham · NCT05656105
Determinants of SARS (Severe Acute Respiratory Syndrome)-COV2 (COVID-19) Persistence After Convalescence
Phase N/A · 1 location(s) · Columbia University · NCT04448145
NC Testing in LC & POTS
NA · 1 location(s) · University of Calgary · NCT05914649
Predictors of Post-COVID-19 Clinical and Cognitive Consequences
Phase N/A · 1 location(s) · VA Office of Research and Development · NCT06291870
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.